Eli Lilly has responded to criticism of high prices for insulin products in the US by launching a cut-price version of its Humalog brand ... five-pack of injectable pens, says Lilly, which ...
Hosted on MSN11mon
Drug manufacturer Eli Lilly says two of its diabetes drugs are in short supply - as millions of patients face weeks of chaosBut when adjusted for inflation, Eli Lilly’s list price for Humalog increased ... said they ration their insulin supplies to save money. Shortages will affect non-pen injectable insulins through ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition ... which is available in vial form or as a disposable pen. Sanofi fights back This represents Sanofi's first foray into ...
Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...
Objective: To assess the functionality and patient acceptability of HumaPen Ergo ®, a new 3.0ml reusable insulin pen. Design: Patients trialled HumaPen Ergo ® (Eli Lilly) over 5 to 7 weeks and ...
Eli Lilly said it would institute the cap on out-of-pocket costs for Lilly insulin users immediately as it prepares to cut the list price of two of its most commonly prescribed insulins ...
Six years ago, the average monthly out-of-pocket cost for insulin made by Eli Lilly ... them instead. Lilly, for example, recently revealed that the list price of its Humalog insulin held steady ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results